IONS Kyle Jenne sells $86K worth of shares
Apr 18, 2025, 4:36 AM
0.00%
What does IONS do
Ionis Pharmaceuticals, headquartered in Carlsbad, California, develops drugs using antisense technology and has five marketed medicines, including SPINRAZA and QALSODY, with a pipeline focused on neurology and cardiology. The company employs 927 people and has nine medicines in Phase III development.
Kyle Jenne sold 3,016 shares of IONS on 16 April at $28.36 per share, worth a total of $86K. They now own 11,199 IONS shares, or a 21% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.